Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 988 | 2,679 | 709 | 458 | 439 |
| Gross Profit | 988 | 2,679 | 709 | 458 | 439 |
| Operating Expenses | 53,983 | 50,657 | 48,265 | 43,912 | 43,484 |
| Operating Income | -52,995 | -47,978 | -47,556 | -43,454 | -43,045 |
| Other Income | 2,016 | 1,983 | 2,565 | 1,529 | 670 |
| Pre-tax Income | -50,979 | -45,995 | -44,991 | -41,925 | -42,375 |
| Net Income Continuous | -50,979 | -45,995 | -44,991 | -41,925 | -42,375 |
| Net Income | $-50,979 | $-45,995 | $-44,991 | $-41,925 | $-42,375 |
| EPS Basic Total Ops | -0.94 | -0.85 | -0.83 | -0.78 | -0.81 |
| EPS Basic Continuous Ops | -0.94 | -0.85 | -0.84 | -0.78 | -0.81 |
| EPS Diluted Total Ops | -0.94 | -0.85 | -0.83 | -0.78 | -0.81 |
| EPS Diluted Continuous Ops | -0.94 | -0.85 | -0.84 | -0.78 | -0.81 |
| EBITDA(a) | $-53,626 | $-48,225 | $-47,627 | $-43,338 | $-42,635 |